THE IMPACT OF DRUG–ELUTING STENT TYPE ON LATE RESTENOSIS AND LATE REGRESSION

Although several studies have reported late regression after bare–metal stent (BMS) implantation, little is known about late regression after drug–eluting stent (DES) implantation. From November 2002 to December 2011, 12069 consecutive patients (17272 lesions) were treated with sirolimus–